AN2 Therapeutics, Inc. (ANTX)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
XHAM $
4. 68
+0.01
+0.2141%
$
130.43M Market Cap
- P/E Ratio
- Div Yield
66,100 Volume
- Eps
$ 4.67
Previous Close 
Want to track ANTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ANTX Earnings Reports FAQ
What is the earnings per share (EPS) for ANTX?
EPS data for ANTX is currently not available, as AN2 Therapeutics, Inc has not reported recent earnings.
What is the company's earnings growth rate?
AN2 Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
AN2 Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for AN2 Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ANTX at this time, as AN2 Therapeutics, Inc has no recent EPS data to calculate it.
